WilmerHale Advises Thermo Fisher on its CHF 1.425 Billion Offering of Bonds

WilmerHale Advises Thermo Fisher on its CHF 1.425 Billion Offering of Bonds

Client News

Related Solutions

Leveraging our sophisticated technical, market and legal experience to help clients effectively and efficiently manage complex transactions and get the deal done.
Advising life sciences innovators, investors and industry leaders on complex transactions, legal issues and business challenges.
A deep and diverse practice focused on maximizing tax efficiencies and minimizing tax risks for clients nationally and internationally.

WilmerHale acted as US special counsel to Thermo Fisher Scientific Inc. in connection with its offer and sale of CHF-denominated bonds, in an offering that was the largest Swiss franc bond issuance from a US corporate issuer in history. The offering consisted of CHF 410,000,000 aggregate principal amount of 0.8320% Bonds due 2026, CHF 315,000,000 aggregate principal amount of 1.1250% Bonds due 2029, CHF 350,000,000 aggregate principal amount of 1.4175% Bonds due 2033, CHF 215,000,000 aggregate principal amount of 1.6524% Bonds due 2037 and CHF 135,000,000 aggregate principal amount of 1.8975% Bonds due 2045, each to be listed on the SIX Swiss Exchange. The offering priced on February 26, 2025 and closed on March 7, 2025. UBS AG, acting through its business division, UBS Investment Bank, BNP Paribas (Suisse) SA and Deutsche Bank AG London Branch, acting through Deutsche Bank AG Zurich Branch, acted as the joint lead managers for the offering.

The WilmerHale team advising Thermo Fisher Scientific Inc. on the offering consisted of Molly Fox, Andrew Langworthy, Rachael Joseph and Tim Kolankowski (Capital Markets), with assistance from Meghan Walsh and Benjamin Kelsey (Tax).

Notice

We appreciate your interest in WilmerHale. While we are pleased to have you contact us, please keep in mind that merely contacting WilmerHale does not create an attorney-client relationship. Such a relationship will not arise until the Firm agrees in writing to represent you in connection with a particular matter. Importantly, unless and until this has occurred, you should not provide us with any confidential information, and we have no duty to keep confidential any information that we may receive from you. Thank you for your understanding.

I Accept Cancel